Japanese Journal of Clinical Oncology Advance Access originally published online on June 9, 2009
Japanese Journal of Clinical Oncology 2009 39(8):497-501; doi:10.1093/jjco/hyp056
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author (2009). Published by Oxford University Press. All rights reserved
No Association of the NFKB1 Insertion/Deletion Promoter Polymorphism with Survival in Patients with Gastric Cancer
1 Department of Oncology/Hematology, Kyungpook National University Hospital, Kyungpook National University School of Medicine
2 Department of Radiology, Kyungpook National University Hospital, Kyungpook National University School of Medicine
3 Department of the Advanced Medical Technology Center for Diagnosis and Prediction, Kyungpook National University Hospital, Kyungpook National University School of Medicine
4 Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook National University School of Medicine
5 Department of Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea
For reprints and all correspondence: Wansik Yu, Department of Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine, 50 Samduck 2-Ga, Jung-Gu, Daegu 700-712, Korea. E-mail: wyu{at}mail.knu.ac.kr
Received February 27, 2009; accepted May 4, 2009
Objective: The present study analyzed the functional insertion/deletion polymorphism in the promoter region of NFKB1 gene and their impact on the prognosis for patients with gastric adenocarcinoma.
Methods: Four hundred and seventy two consecutive patients with curatively resected gastric adenocarcinoma were enrolled in the present study. The genomic DNA was extracted from paraffin-embedded tissue and the –94 insertion/deletion ATTG polymorphism of NFKB1 determined using a polymerase chain reaction–restriction fragment length polymorphism assay.
Results: The NFKB1 promoter gene polymorphism was successfully amplified in 97.8% of the cases. There were no sexual differences in relation to the genotype and allele. No correlation was observed between the frequency of the genotype or allele and the T, N or M stage. The multivariate survival analysis showed no association between the NFKB1 –94 insertion/deletion promoter polymorphism and the disease-free survival or overall survival of the patients with gastric cancer.
Conclusions: The functional NFKB1 promoter polymorphism was not found to be a prognostic marker for Korean patients with surgically resected gastric adenocarcinoma.
Key Words: gastric cancer NFKB1 polymorphism prognosis